These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 4999322)
1. [Controlled clinical study of the blood pressure lowering effect of a rauwolfia-saluretic combination, with and without addition of an adrenolytic agent]. Esch I; Wohlzogen FX; Scheiber V Wien Z Inn Med; 1971; 52(5):265-71. PubMed ID: 4999322 [No Abstract] [Full Text] [Related]
2. [Design and evaluation of a clinical study comparing combinations of antihypertensive agents]. Scheiber V; Wohlzogen FX; Esch I Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):346-51. PubMed ID: 4996196 [No Abstract] [Full Text] [Related]
3. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid]. Wanner J Schweiz Med Wochenschr; 1968 Aug; 98(32):1196-201. PubMed ID: 4974016 [No Abstract] [Full Text] [Related]
4. [Use of DCR-515 in the treatment of arterial hypertension]. da Cunha GP; Riskala R; Mulinari AS Hospital (Rio J); 1968 Dec; 74(6):2061-72. PubMed ID: 4977024 [No Abstract] [Full Text] [Related]
5. Design and analysis of a clinical trial of antihypertensives. Wohlzogen FX Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):157-60. PubMed ID: 4992896 [No Abstract] [Full Text] [Related]
6. [On several anti-hypertensive drugs with special reference to the association of dihydroergocristine, reserpine and clopamide]. Martinetti L; Lai G Arch Maragliano Patol Clin; 1970; 26(3):209-18. PubMed ID: 5002193 [No Abstract] [Full Text] [Related]
11. [Clinical experience using DCR-515 in the treatment of essential arterial hypertension (preliminary communication)]. Elizalde JE Hospital (Rio J); 1968 Dec; 74(6):2073-5. PubMed ID: 4977025 [No Abstract] [Full Text] [Related]
12. [Treatment of hypertension]. Kulke H Fortschr Med; 1972 Dec; 90(35):1318-20. PubMed ID: 4633069 [No Abstract] [Full Text] [Related]
13. [Clinical experience using DCR-515 in the treatment of essential arterial hypertension (final communication)]. Elizalde JE Hospital (Rio J); 1968 Dec; 74(6):2077-81. PubMed ID: 4977026 [No Abstract] [Full Text] [Related]
14. [Principles of combining hypotensive agents (review of the literature)]. Kazak LI Vrach Delo; 1974; 4():1-4. PubMed ID: 4151617 [No Abstract] [Full Text] [Related]
15. [Experiences with a new antihypertensive agent]. Stampfer E Wien Klin Wochenschr; 1971 Jan; 83(4):66-9. PubMed ID: 4994618 [No Abstract] [Full Text] [Related]
16. [Further clinico-therapeutic aspects of therapy of arterial hypertension]. Anselmo B; Basso L Clin Ter; 1971 Jan; 56(1):55-70. PubMed ID: 5002870 [No Abstract] [Full Text] [Related]
17. [Clinical experience report on the combination antihypertensive agents DCR 1015 and DCR 515]. Obrowsky L; Kern H Wien Med Wochenschr; 1969 Jan; 119(2):36-9. PubMed ID: 4976539 [No Abstract] [Full Text] [Related]
18. [Effect of a combination of dihydroergocristine methanesulfonate, clopamide and reserpine on blood pressure and renal hemodynamics in renal and essential hypertension]. Ludwig H; Thielecke R; Weichert G Arzneimittelforschung; 1970 Aug; 20(8):1079-83. PubMed ID: 5536507 [No Abstract] [Full Text] [Related]
19. [Regulation of renin secretion in saluretic-induced sodium loss]. Zehner J; Ebel H; Klaus D; Witzgall H Verh Dtsch Ges Kreislaufforsch; 1977; 43():210-1. PubMed ID: 613576 [No Abstract] [Full Text] [Related]
20. Clinical experience with dihydroergocristine-reserpine-clopamide combination (brinerdin) in Ghanaian hypertensives. Bandoh JK Ghana Med J; 1973 Jun; 12(2):166-76. PubMed ID: 4218686 [No Abstract] [Full Text] [Related] [Next] [New Search]